These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 769101)

  • 1. [Role of immunotherapy in the treatment of leukemias].
    Alexander P
    Recenti Prog Med; 1975 Oct; 59(4):301-13. PubMed ID: 769101
    [No Abstract]   [Full Text] [Related]  

  • 2. [BCG, or immunotherapy of hope].
    Monti A
    Minerva Med; 1975 Oct; 66(68 Suppl):7-9. PubMed ID: 1059000
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of immunotherapy in acute myelogenous leukemia.
    Foon KA; Smalley RV; Riggs CW; Gale RP
    Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of chemotherapy and immunotherapy in the treatment of patients with acute myeloblastic leukemia (proceedings)].
    Russell JA; Powles RL
    Minerva Med; 1977 Oct; 68(51):3528-32. PubMed ID: 270618
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of immunotherapy of acute leukemias with BCG vaccine of Polish production].
    Kardaszewicz E; Japa J
    Acta Haematol Pol; 1975; 6(2):149-55. PubMed ID: 1057344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of leukemia and lymphoma.
    Murphy S; Hersh E
    Semin Hematol; 1978 Apr; 15(2):181-203. PubMed ID: 418506
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of acute myelogenous leukemia in man.
    Powles R
    Natl Cancer Inst Monogr; 1973 Dec; 39():243-7. PubMed ID: 4595324
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of acute leukemias and linphosarcomas with active immunotherapy (author's transl)].
    Mathe G; Amiel JL; Schwarsenberg L; Hyat M; Pouillart P; Schenider M; Cattan A; Jasmin C; Belpomme D; Schulmberger JR; De Vassal F; Musset M; Misset JL
    Folia Clin Int (Barc); 1975 Mar; 25(3):131-51. PubMed ID: 1056311
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy of leukaemia.
    Malpas JS
    Schweiz Med Wochenschr; 1974 May; 104(18):626-33. PubMed ID: 4596725
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy in acute leukemias. Possible applications in children.
    Mahoney DH; Starling KA
    Am J Pediatr Hematol Oncol; 1981; 3(4):410-8. PubMed ID: 7036781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of human leukemia.
    Baker MA; Taub RN
    Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
    [No Abstract]   [Full Text] [Related]  

  • 12. Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man.
    Mathé G; Hayat M; Amiel JL; Schwarzenberg L; Schneider M; Pouillart P; Cattan A
    Boll Ist Sieroter Milan; 1971; 50(4):251-9. PubMed ID: 5293498
    [No Abstract]   [Full Text] [Related]  

  • 13. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of treatment of acute leukaemias with BCG vaccine.
    Kardaszewicz E; Japa J
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):20-4. PubMed ID: 1063220
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy with BCG and leukemic blast cells during complete remission of acute myeloid leukemia.
    Gobbi M; Ruggero D; Baccarani M; Zaccaria A; Tomasini I; Tura S
    Haematologica; 1977 Oct; 62(5):529-36. PubMed ID: 412739
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemo-immunotherapy versus chemotherapy in acute myeloid leukemia. Preliminary results.
    Fiere D; Doillon M; Martin C; Vu Van T; Revol L
    Biomedicine; 1976 Dec; 25(9):318. PubMed ID: 1069595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of active immunotherapy of acute myeloid leukemia.
    Mathé G; Musset M; Schwarzenberg L; Hayat M; de Vassal F; Amiel JL; Pouillart P; Misset JL
    Biomedicine; 1975 Sep; 23(7):291-3. PubMed ID: 1066168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active specific immunotherapy for acute myelogenous leukaemia.
    Powles R
    Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
    Powles R; Toy JL
    Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent data on the immunotherapy of leukemias].
    Mathe G; Schwarzenberg L; Amiel JL; Pouillart P; Hayat M; De Vassal F; Rosenfeld C; Jasmin C
    Recenti Prog Med; 1975 Oct; 59(4):314-29. PubMed ID: 769102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.